Fiona Simpkins

12PUBLICATIONS
79CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 26, 2026
Molecular Response Assessment From Circulating Tumor DNA in Patients With Ovarian Cancer Treated With the WEE1 Inhibitor Azenosertib.

|Apr 01, 2025
Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR.

Haineng Xu, Erin George, David Gallo

|Jan 16, 2025
Olaparib as treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency: Phase 2 LIGHT study final overall survival analysis.

Ying L Liu, Cara A Mathews, Fiona Simpkins

|Feb 27, 2024
Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR.

Haineng Xu, Erin George, David Gallo

|Oct 26, 2023
A B7-H4-Targeting Antibody-Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression.

Sarah B Gitto, Margaret Whicker, Gareth Davies

|Oct 16, 2023
Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer.

Yasuto Kinose, Haineng Xu, Hyoung Kim

Pageof 2

Frequent Collaborators

6 joint publications

Hyoung Kim

5 joint publications

Haineng Xu

4 joint publications

Gordon B Mills

3 joint publications

Eric J Brown